Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
about
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceAnticancer mechanisms of cannabinoidsAlternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesThe dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcriptionSubstrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen ProbesCannabinoids, endocannabinoids, and cancerProtein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.A population-based case-control study of marijuana use and head and neck squamous cell carcinomaMinireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma.Energetic metabolism and human sperm motility: impact of CB₁ receptor activationChemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice.Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival.Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells.Prostaglandin E2 promotes intestinal tumor growth via DNA methylation.Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent.Critical appraisal of the potential use of cannabinoids in cancer management.Emerging strategies for exploiting cannabinoid receptor agonists as medicines.The endocannabinoid system and sex steroid hormone-dependent cancers.Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway.Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies.Off-target cannabinoid effects mediated by GPR55.Epigenetic mechanisms and endocannabinoid signalling.Targeting cannabinoid receptors in gastrointestinal cancers for therapeutic uses: current status and future perspectives.Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.Antitumorigenic targets of cannabinoids - current status and implications.Endocannabinoids in the gastrointestinal tract.The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.
P2860
Q26739831-64B44643-2998-4D99-815E-45102C4E5EB2Q26750399-A9A40B1E-DA4C-437F-B47E-D02164C5DE4EQ26824588-6B025E33-2A8C-498C-8595-74F236EFCAEEQ27026491-3D374342-04E6-4A0A-8956-94A7C3DBDA20Q27673277-F1B10D6C-D2D5-4D37-ACBA-0783D38935BAQ27694715-A1A00341-677D-4F6C-B172-3680010B1590Q33607616-339DCF7F-931F-40DB-903F-95F146CF2E62Q33616287-4C3C4B35-BAB8-47DC-85D0-DB6D01D2C3A2Q33636763-918750B9-DC95-48B9-A1D4-59896449C8D4Q33680523-EDD58287-FA28-46F5-B131-BA1D8531F621Q33784488-CF6A736F-B64B-45A5-A783-BD9DB3A2E007Q33914549-E37AF9F0-8FC1-4325-B1F3-832938D68067Q34013690-0F14C19C-F72B-4C17-9FC9-9C1905E3280AQ34049715-A0B4269B-30CD-46AA-84AB-BAACAD377AE3Q34298903-E48D9BD4-82DB-443E-BD04-0BD9FECF76EBQ34338079-7DF81733-1708-4931-A050-0F1DAA5C88C6Q34392678-6FCE512A-B972-412C-B4C0-9A471021B4B0Q34635002-284E8726-D0A9-4268-B167-06D72C315CE0Q34766747-05776135-C56C-42F1-88F1-7811B3FBBD4EQ34890499-80296C0E-67D5-46A0-A6A0-F410B28F6223Q35122796-6E5D2EC1-77CC-4879-81DF-E3FD1545EAB3Q35224267-9D7F4FD5-C1FC-4104-ABBC-BC983F807BD7Q35238992-11C01B31-502A-450A-BBF2-0BFC6898AEABQ35646098-857C26F5-534A-4AA9-AA43-C730C2075400Q35742739-39C65606-DEC6-453E-938F-D4E25F99F255Q35760870-E2927F88-D9EC-4934-8432-A092D3A41BB6Q36843205-1C4A003C-1B36-46D9-B56A-C43CA7B2F73AQ37164208-F4637FAD-6053-4E22-8B56-4CDC91416C2AQ37230665-97A88F50-8582-40D0-8166-248C8E6841CCQ37393042-CD9D6EE7-A0B1-4C75-A6F0-0261503A598FQ37546194-67DB2E3C-A4DD-4028-8807-55458FD078F8Q37708853-3AB2DBA3-1DAA-43E3-94D6-1A992B9B49FFQ37960078-099E5C88-2C61-4A84-AA3B-C473D6C7E0B7Q37995375-E8561AB3-560D-404D-9347-0C1213DFBE80Q38072984-4E88B196-E444-4BCC-829A-C5608D80D99BQ38640858-6D7EC663-9414-49D4-9014-9EEC4BD49CB0Q38761437-AB67B9CD-AF04-46D5-99BE-5DA42CF963EFQ38806270-2ECE688F-7D80-4F8A-B920-E78126323748Q38931168-693D7AC4-552C-4947-B8DA-105C05E6227EQ38937293-A7B72604-7200-430F-A86B-16FB78FCB5FE
P2860
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
@en
type
label
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
@en
prefLabel
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
@en
P2093
P2860
P921
P1433
P1476
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
@en
P2093
Dingzhi Wang
Haibin Wang
Michael G Backlund
Raymond N DuBois
Sudhansu K Dey
P2860
P304
P356
10.1158/0008-5472.CAN-08-0896
P407
P577
2008-08-01T00:00:00Z